I've spent a career in investing with plenty of time dealing with start-ups. To me AXP seems to be going through teething issues like virtually every other start-up I've ever invested in/been involved in. Underestimating capital to get to b/e and misfiring on the sales strategy are pretty common. Obviously, I'd like to see a CR done when the SP has recovered a bit, but my average buy price is ~9c so even a CR at this price doesn't bother me as long as I'm right about the product's potential.
We are all positive now :), page-92
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AXP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
-0.001(25.0%) |
Mkt cap ! $5.824M | |||
| Open | High | Low | Value | Volume |
| 0.1¢ | 0.2¢ | 0.1¢ | $6.001K | 5.059M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 41585905 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 83677901 | 59 |
View Market Depth
| Last trade - 15.59pm 03/12/2024 (20 minute delay) ? |
| AXP (ASX) Chart |
